Table 2.
Clinical performance of the IMMY sōna Aspergillus GM lateral flow assay when testing serum samples from non-neutropenic patients with pulmonary infections and control healthy individuals using ROC based cut-off values.
| Performance Parameter | ROC Based Cut-Off Value | ||
|---|---|---|---|
| 0.36 | 0.48 | 0.48 | |
| Sensitivity (95% CI) | 90% (82.2–95%) | 80% (70.8–87.3%) | 80% (70.8–87.3%) |
| Specificity (95% CI) | 72% (62.1–80.5%) | 80% (70.8–87.3%) | 80% (70.8–87.3%) |
| Accuracy (95% CI) | 81% (74.9–86.2%) | 80% (73.8–85.3%) | 80% (73.8–85.3%) |
| Positive Likelihood Ratio (95% CI) | 3.211 (2.329–4.427) | 3.990 (2.663–5.978) | 3.990 (2.663–5.978) |
| Negative Likelihood Ratio (95% CI) | 0.140 (0.077–0.256) | 0.253 (0.169–0.378) | 0.253 (0.169–0.378) |